A pasteurized form of the gut bacterium Akkermansia muciniphila MucT was associated with reduced weight regain after a low-energy diet, according to a randomized trial published in Nature Medicine. The 24-week study enrolled 90 overweight and obese adults in the Netherlands and reported a statistically significant difference in weight regain between the treatment and placebo groups.

What did the study find?

Participants first lost 8 percent of their body weight during an eight-week low-energy diet before being randomized. During the 24-week weight-maintenance phase, 45 participants received pasteurized Akkermansia and 45 received a placebo. Those taking Akkermansia regained an average of 2.6 pounds, compared with 7.1 pounds in the placebo group, a difference the researchers described as statistically significant. No serious adverse events were attributed to the treatment, and the researchers reported that efficacy depended on each participant’s existing gut microbiome composition.

How was the trial designed?

The trial was randomized and ran for 24 weeks, with the bacterium or placebo delivered during a maintenance phase that followed an eight-week low-energy diet. The study recruited overweight and obese adults in the Netherlands. Because participants were not placed on a standardized diet during the maintenance period and instead ate as they chose, the researchers flagged diet variability as a potential influence on outcomes. The team also acknowledged that the 24-week duration and 90-person sample may not be enough to demonstrate long-term benefits.

How might Akkermansia work in the body?

Dr. Peter Balazs, a hormone and weight loss specialist practicing in New York and New Jersey who was not involved in the study, called the trial well-designed in comments to Fox News Digital. He noted that a single gut microbe significantly reducing weight regain is striking, because most probiotics have shown far less efficacy in studies. Balazs explained that pasteurized Akkermansia is not a live probiotic. It works through components of the bacterium, particularly a protein called Amuc_1100, which he said helps strengthen the gut barrier, reduce low-grade inflammation, and support healthy metabolic function.

After weight loss, the body tends to push back toward regaining fat. Balazs said Akkermansia appears to help quiet some of those biological signals, which could make maintaining results easier over time. He cautioned that Akkermansia is not a miracle pill, that it supports maintenance rather than initial loss, and that long-term use beyond 24 weeks has not been proven. He also stressed that the bacterium does not replace diet, exercise, or medical advice.

What are the limitations?

Researchers and outside experts pointed to several constraints. The trial lasted 24 weeks and enrolled 90 participants, leaving long-term outcomes and broader population effects uncertain. The maintenance phase did not standardize diet, so participants’ food choices could have influenced results. The bacterium’s effectiveness also appeared to depend on each person’s existing gut microbiome, meaning responses may vary. A 2019 alert from ANH International previously cautioned that no single organism is likely to be a panacea, a view echoed by both Balazs and the study team.

Where does this fit in microbiome research?

The findings build on earlier work on the gut microbiome’s role in metabolism, immunity, and brain function. A 2019 NaturalNews.com report noted that scientists had been investigating Akkermansia for potential weight loss benefits. A 2025 article observed that pomegranate juice stimulates gut mucus production, creating conditions in which Akkermansia can thrive, and a 2026 guide listed foods associated with boosting Akkermansia levels. Books on the microbiome have also linked diet-influenced bacterial species to weight regulation.

Further studies with longer follow-up periods and larger populations are needed to confirm the findings, clarify optimal dosing and delivery, and map which baseline microbiomes respond best. The researchers suggested that, once the bacterium is better understood, dietary strategies to raise Akkermansia naturally, including polyphenol- and fiber-rich foods, may play a larger role in weight management protocols.

FAQ

What is Akkermansia muciniphila?

Akkermansia muciniphila is a gut bacterium studied for its links to metabolic health. The recent trial used a pasteurized, non-live form of the strain called MucT, which delivers bacterial components such as the protein Amuc_1100 rather than acting as a live probiotic.

How much less weight did participants regain on Akkermansia?

Across the 24-week maintenance phase, participants taking pasteurized Akkermansia regained an average of 2.6 pounds, compared with 7.1 pounds in the placebo group, a difference the researchers described as statistically significant.

Is Akkermansia a replacement for diet and exercise?

No. Both Dr. Peter Balazs and the study authors cautioned that Akkermansia is not a standalone solution and does not replace diet, exercise, or medical advice. Long-term use beyond 24 weeks has not been studied, and the bacterium appears to support weight maintenance rather than initial weight loss.

This article summarizes reporting from naturalnews.com.